Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Terminating AFib for good | The evolution of AI in cardiology | Predicting LBBB risk after TAVR | Key FDA approvals

News You Need to Know Today
Terminating AFib for good | The evolution of AI in cardiology | Predicting LBBB risk after TAVR | Key FDA approvals
Wednesday, May 7, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Artificial intelligence

AI helps cardiologists terminate AFib for good with ablation

Advanced AI can provide real-time feedback to cardiologists, helping them deliver high-quality care. 

READ MORE >
AI healthcare doctor surgery procedure artificial intelligence
Share on Twitter Share on Facebook Share on Linkedin

AI helps cardiologists terminate AFib for good with ablation

Share on Twitter Share on Facebook Share on Linkedin
AI healthcare doctor surgery procedure artificial intelligence
Advanced AI can provide real-time feedback to cardiologists, helping them deliver high-quality care. 
READ MORE >

Exploring the evolution of AI in cardiology

Partho Sengupta, MD, shared his perspective on the current state of artificial intelligence in cardiology. The technology continues to evolve, he said, though it does still face certain limitations.

READ MORE >
Partho Sengupta, MD, DM, FACC, FASE, Henry Rutgers Professor of Cardiology and Chief of Cardiovascular Medicine, at Robert Wood Johnson Medical School, and Chief of the Cardiovascular Service Line at Robert Wood Johnson University Hospital, offers an overview of the current state of artificial intelligence (AI) in cardiology. He offers insights from what he has seen from some of the more than 160 FDA-cleared algorithms specific to cardiovascular medicine and what is in development.
Share on Twitter Share on Facebook Share on Linkedin

Exploring the evolution of AI in cardiology

Share on Twitter Share on Facebook Share on Linkedin
Partho Sengupta, MD, DM, FACC, FASE, Henry Rutgers Professor of Cardiology and Chief of Cardiovascular Medicine, at Robert Wood Johnson Medical School, and Chief of the Cardiovascular Service Line at Robert Wood Johnson University Hospital, offers an overview of the current state of artificial intelligence (AI) in cardiology. He offers insights from what he has seen from some of the more than 160 FDA-cleared algorithms specific to cardiovascular medicine and what is in development.
Partho Sengupta, MD, shared his perspective on the current state of artificial intelligence in cardiology. The technology continues to evolve, he said, though it does still face certain limitations.
READ MORE >

AI predicts LBBB risk in TAVR patients prior to treatment

The authors tested out a variety of machine learning techniques, including large language models and more traditional algorithms. They focused on data that can be gathered prior to treatment, ensuring cardiologists know as much as possible before the procedure.

READ MORE >
artificial intelligence heart AI
Share on Twitter Share on Facebook Share on Linkedin

AI predicts LBBB risk in TAVR patients prior to treatment

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence heart AI
The authors tested out a variety of machine learning techniques, including large language models and more traditional algorithms. They focused on data that can be gathered prior to treatment, ensuring cardiologists know as much as possible before the procedure.
READ MORE >

FDA approves new AI-enabled wearable cardioverter defibrillator

The newly approved device can be worn for up to a week at a time, with no daily maintenance required, and includes advanced AI algorithms that minimize the risk of false alarms or inappropriate shocks.

READ MORE >
Jewel Patch Wearable Cardioverter Defibrillator from Element Science
Share on Twitter Share on Facebook Share on Linkedin

FDA approves new AI-enabled wearable cardioverter defibrillator

Share on Twitter Share on Facebook Share on Linkedin
Jewel Patch Wearable Cardioverter Defibrillator from Element Science
The newly approved device can be worn for up to a week at a time, with no daily maintenance required, and includes advanced AI algorithms that minimize the risk of false alarms or inappropriate shocks.
READ MORE >

AI-based coronary plaque evaluations highlight elevated heart risks in women

“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.

READ MORE >
Gudrun Feuchtner, MD, MBA, HCM, assistant professor, cardiovascular imaging, Medical University Innsbruck, Department Radiology, explains how artificial intelligence-based quantitative computed tomography (AI QCT) coronary plaque features are better able to predict risk in women, according the the results of the late-breaking CONFIRM2 study at ACC 2025.
Share on Twitter Share on Facebook Share on Linkedin

AI-based coronary plaque evaluations highlight elevated heart risks in women

Share on Twitter Share on Facebook Share on Linkedin
Gudrun Feuchtner, MD, MBA, HCM, assistant professor, cardiovascular imaging, Medical University Innsbruck, Department Radiology, explains how artificial intelligence-based quantitative computed tomography (AI QCT) coronary plaque features are better able to predict risk in women, according the the results of the late-breaking CONFIRM2 study at ACC 2025.
“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.
READ MORE >

AI-powered risk model evaluates long-term risk of coronary artery disease

The advanced machine learning model tracks more than 50 different factors to make its predictions. It has already been found to be more accurate than popular prediction methods for heart disease that are currently available. 

READ MORE >
artificial intelligence AI heart cardiology
Share on Twitter Share on Facebook Share on Linkedin

AI-powered risk model evaluates long-term risk of coronary artery disease

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI heart cardiology
The advanced machine learning model tracks more than 50 different factors to make its predictions. It has already been found to be more accurate than popular prediction methods for heart disease that are currently available. 
READ MORE >

FDA clears AI-powered echocardiography software

HeartFocus guides users through the entire process, making it so that even novices can deliver high-quality echocardiograms every time.

READ MORE >
HeartFocus DESKi
Share on Twitter Share on Facebook Share on Linkedin

FDA clears AI-powered echocardiography software

Share on Twitter Share on Facebook Share on Linkedin
HeartFocus DESKi
HeartFocus guides users through the entire process, making it so that even novices can deliver high-quality echocardiograms every time.
READ MORE >

Nonprofit group helps doctors and startups bring new cardiovascular tech to market

Nabil Dib, MD, founder of the International Society for Cardiovascular Translational Research, details resources to help doctors and startups navigate the shift from conducting research to commercializing new products and applications.

READ MORE >
Nabil Dib, MD, director clinical and translational research, Dignity Health, and founder of the non-profit International Society for Cardiovascular Translational Research (ISCTR), explains resources ISCTR has to help doctors and start ups navigate regulatory pathways to expedite moving from research to clinical application.
Share on Twitter Share on Facebook Share on Linkedin

Nonprofit group helps doctors and startups bring new cardiovascular tech to market

Share on Twitter Share on Facebook Share on Linkedin
Nabil Dib, MD, director clinical and translational research, Dignity Health, and founder of the non-profit International Society for Cardiovascular Translational Research (ISCTR), explains resources ISCTR has to help doctors and start ups navigate regulatory pathways to expedite moving from research to clinical application.
Nabil Dib, MD, founder of the International Society for Cardiovascular Translational Research, details resources to help doctors and startups navigate the shift from conducting research to commercializing new products and applications.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Risk of death jumps when COVID-19 patients have CVD & myocardial injury | Stories from the front lines of the pandemic
Week in Review: Cardiac injury & COVID-19 | The pandemic's impact on healthcare workers | How statins can reduce HF risk
Caring for COVID-19 patients leads to depression, distress for healthcare workers | More cardiology conferences canceled
Coronary Intervention & Surgery | March 2020
Cardiac injury in COVID-19 patients | Outcomes for homeless patients after heart attacks
The biggest COVID-19 news in cardiology, all in one place
Key data from the 2020 Cardiovascular Leadership Survey | COVID-19 updates | Low-dose aspirin recommendations

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …344
    • Page 345
    • Page 346
    • Page 347
    • Page 348
    • Current page 349
    • Page 350
    • Page 351
    • Page 352
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup